About Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology is a company based in Haidian (China) founded in 2015 by Wenjun Yang. Beijing Xinyi Biotechnology has raised $23.19 million across 3 funding rounds from investors including Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital. Beijing Xinyi Biotechnology operates in a competitive market with competitors including NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Kryptos Biotechnologies, among others.
- Headquarter Haidian, China
- Founders Wenjun Yang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.19 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Jiuzhi Capital
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has successfully raised a total of $23.19M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Beijing Xinyi Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beijing Xinyi Biotechnology
Investment portfolio details for Beijing Xinyi Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Beijing Xinyi Biotechnology
Detailed financials for Beijing Xinyi Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beijing Xinyi Biotechnology Comparisons
Peer comparison for Beijing Xinyi Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Kryptos Biotechnologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Provider of point of care molecular diagnostics solutions
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
Detailed competitors of Beijing Xinyi Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beijing Xinyi Biotechnology
Complete news archive for Beijing Xinyi Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Beijing Xinyi Biotechnology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Beijing Xinyi Biotechnology is a funded company, having raised a total of $23.19M across 3 funding rounds to date.
Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.
Beijing Xinyi Biotechnology's top competitors include GenMark Diagnostics, NeuMoDx and Altratech.
Beijing Xinyi Biotechnology has 5 investors. Key investors include Jiuzhi Capital, Lilly Asia Ventures, China Growth Capital, Hillhouse, and Huade Capital Management Group.